These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19301972)

  • 21. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
    Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
    Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease.
    Tykocki T; Nauman P; Koziara H; Mandat T
    Stereotact Funct Neurosurg; 2013; 91(1):12-7. PubMed ID: 23154788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease.
    Peppe A; Pierantozzi M; Bassi A; Altibrandi MG; Brusa L; Stefani A; Stanzione P; Mazzone P
    J Neurosurg; 2004 Aug; 101(2):195-200. PubMed ID: 15309908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
    Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
    J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The added value of semimicroelectrode recording in deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Jonker PK; van Dijk JM; van Hulzen AL; van Laar T; Staal MJ; Journée HL
    Neurosurg Focus; 2013 Nov; 35(5):E3. PubMed ID: 24175863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
    Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
    Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotion recognition in Parkinson's disease after subthalamic deep brain stimulation: differential effects of microlesion and STN stimulation.
    Aiello M; Eleopra R; Lettieri C; Mondani M; D'Auria S; Belgrado E; Piani A; De Simone L; Rinaldo S; Rumiati RI
    Cortex; 2014 Feb; 51():35-45. PubMed ID: 24342106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae.
    Gologorsky Y; Ben-Haim S; Moshier EL; Godbold J; Tagliati M; Weisz D; Alterman RL
    Neurosurgery; 2011 Aug; 69(2):294-9; discussion 299-300. PubMed ID: 21389886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing accuracy of the magnetic resonance imaging-computed tomography fusion images to evaluate the electrode positions in subthalamic nucleus after deep-brain stimulation.
    Shin M; Penholate MF; Lefaucheur JP; Gurruchaga JM; Brugieres P; Nguyen JP
    Neurosurgery; 2010 Jun; 66(6):1193-202; discussion 1202. PubMed ID: 20495435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of 3T Magnetic Resonance Imaging for Targeting the Human Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease.
    Longhi M; Ricciardi G; Tommasi G; Nicolato A; Foroni R; Bertolasi L; Beltramello A; Moretto G; Tinazzi M; Gerosa M
    J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):181-9. PubMed ID: 25764475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording.
    Reck C; Maarouf M; Wojtecki L; Groiss SJ; Florin E; Sturm V; Fink GR; Schnitzler A; Timmermann L
    J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):377-86. PubMed ID: 23042143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia.
    Cersosimo MG; Raina GB; Benarroch EE; Piedimonte F; Alemán GG; Micheli FE
    Mov Disord; 2009 Jul; 24(10):1488-93. PubMed ID: 19475579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microelectrode recording-determined subthalamic nucleus length not predictive of stimulation-induced side effects.
    McClelland S; Kim B; Winfield LM; Ford B; Edwards TA; Pullman SL; Yu Q; McKhann GM; Goodman RR
    Neurosurg Focus; 2005 Nov; 19(5):E13. PubMed ID: 16398463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Strange Case of Downward Displacement of a Deep Brain Stimulation Electrode 10 Years Following Implantation: The Gliding Movement of Snakes Theory.
    Iacopino DG; Maugeri R; Giugno A; Giller CA
    World Neurosurg; 2015 Aug; 84(2):591.e1-5. PubMed ID: 25841757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic deep brain stimulation for Parkinson's disease: correlation between locations of oscillatory activity and optimal site of stimulation.
    Guo S; Zhuang P; Hallett M; Zheng Z; Zhang Y; Li J; Li Y
    Parkinsonism Relat Disord; 2013 Jan; 19(1):109-14. PubMed ID: 22981262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.